Predictors of clinical outcome in heart failure patients treated with vasopressin type 2 receptor antagonist
Objectives: There are well-established risk prediction models of in-hospital mortality due to heart failure (HF). However, the predictors of mortality during acute hospitalization in individuals with HF receiving tolvaptan, a vasopressin type 2 receptor antagonist, are poorly understood. Methods: Si...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Fujita Medical Society
2018-08-01
|
Series: | Fujita Medical Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/fmj/4/3/4_2017024/_pdf/-char/en |